Endocarditis: Impact of methicillin-resistant Staphylococcus aureus in hemodialysis patients and community-acquired infection

Journal of Microbiology, Immunology and Infection

Volumn 40, Issue 4, 2007, Pages 317-324

  Kuo, Cheng Bang ^a   Lin, Jung Chung ^b   Peng, Ming Yieh ^b   Wang, Ning Chi ^b   Chang, Feng Yee ^b  

^a TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Community acquired infections; Endocarditis, bacterial; Methicillin resistance; Renal dialysis; Staphylococcus aureus

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; FEMALE; FEVER; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITAL INFECTION; HUMAN; INTRAVENOUS DRUG ABUSE; KIDNEY DYSFUNCTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SEPTIC SHOCK; STAPHYLOCOCCUS INFECTION; VENTILATED PATIENT;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 35748982458     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Netzer RO, Altwegg SC, Zollinger E, Täuber M, Carrel T, Seiler C. Infective endocarditis: determinants of long term outcome. Heart. 2002;88:61-6.
2. Bouza E, Menasalvas A, Muñoz P, Vasallo FJ, del Mar Moreno M, García Fernández MA. Infective endocarditis - a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents, and still a high mortality. Medicine (Baltimore). 2001;80:298-307.
3. Hoen B, Alia F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75-81.
4. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012-21.
5. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, et al. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis. 2005;41:507-14.
6. Ako J, Ikari Y, Hatori M, Hara K, Ouchi Y. Changing spectrum of infective endocarditis: review of 194 episodes over 20 years. Circ J. 2003;67:3-7.
7. Lim TT, Chong FN, O'Brien FG, Grubb WB. Are all community methicillin-resistant Staphylococcus aureus related? A comparison of their mec regions. Pathology. 2003;35:336-43.
8. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002;40:4289-4.
9. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131-9.
10. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35:819-24.
11. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis. 1999;29:797-800.
12. Gosbell IB, Mercer JL, Neville SA, Chant KG, Munro R. Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in South Western Sydney. Pathology. 2001;33:206-10.
13. L'Hériteau F, Lucet JC, Scanvic A, Bouvet E. Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission. JAMA. 1999;282:1038-9.
14. Liassine N, Auckenthaler R, Descombes MC, Bes M, Vandenesch F, Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol. 2004;42:825-8.
15. Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis. 2001;33:990-6.
16. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9: 978-84.
17. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Infect Control Hosp Epidemiol. 1995;16:105-13.
18. Ireland JH, McCarthy JT. Infective endocarditis in patients with kidney failure: chronic dialysis and kidney transplant. Curr Infect Dis Rep. 2003;5:293-9.
19. Doulton T, Sabharwal N, Cairns HS, Schelenz S, Eykyn S, O'Donnell P, et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int. 2003;64:720-7.
20. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-8.
21. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-44.
22. Weinstein L, Rubin RH. Infective endocarditis - 1973. Prog Cardiovasc Dis. 1973;16:239-74.
23. Rabinovich S, Evans J, Smith IM, January LE. A long-term view of bacterial endocarditis. 337 cases 1924 to 1963. Ann Intern Med. 1965;63:185-98.
24. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-4.
25. Hsu RB, Chu SH. Impact of methicillin resistance on clinical features and outcomes of infective endocarditis due to Staphylococcus aureus. Am J Med Sci. 2004;328:150-5.
26. Chang FY, MacDonald BB, Peacock JE, Musher DM, Triplett P, Mylotte JM, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003;82:322-32.
27. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis. 2004;190:1730-8.
28. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, et al. Necrotizing fasciitis caused by community-associated methicillin- resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445-53.
29. Crum NF. The emergence of severe, community-acquired methicillin- resistant Staphylococcus aureus infections. Scand J Infect Dis. 2005;37:651-6.
30. Schulz P, Allen M, Murray Q, Smith SA, Goss L, Carrico R, et al. Infections due to community-acquired methicillin-resistant Staphylococcus aureus: an emergent epidemic in Kentucky. J Ky Med Assoc. 2005;103:194-203.
31. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-32.
32. Begier EM, Frenette K, Barrett NL, Mshar P, Petit S, Boxrud DJ, et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis. 2004;39:1446-53.
33. Nguyen DM, Mascola L, Brancoft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis. 2005;11:526-32.
34. Abbott KC, Agodoa LY. Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron. 2002;91:203-9.
35. Hoen B. Infective endocarditis: a frequent disease in dialysis patients. Nephrol Dial Transplant. 2004;19:1360-2.
36. Chang CF, Kuo BI, Chen TL, Yang WC, Lee SD, Lin CC. Infective endocarditis in maintenance hemodialysis patients: fifteen years' experience in one medical center. J Nephrol. 2004;17:228-35.
37. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int. 2001;60:1-13.
38. Sandroni S, McGill R, Brouwer D. Hemodialysis catheter-associated endocarditis: clinical features, risks, and costs. Semin Dial. 2003;16:263-5.
39. Zibari GB, Rohr MS, Landreneau MD, Bridges RM, De Vault GA, Petty FH, et al. Complications from permanent hemodialysis vascular access. Surgery. 1988;104:681-6.
40. McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc. 2000;75:1008-14.
41. Maraj S, Jacobs LE, Kung SC, Raja R, Krishnasamy P, Maraj R, et al. Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci. 2002;324:254-60.
42. Sexton DJ. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infect Dis Clin North Am. 2001;15:731-42.
43. Boelaert JR, Van Landuyt HW, Godard CA, Daneels RF, Schurgers ML, Matthys EG, et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant. 1993;8:235-9.
44. Cunha BA. Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect. 2005;11(Suppl 4):33-42.
45. Turnidge J, Chang FY, Fowler VG, Rao N. Staphylococcus aureus. In: Yu VL, Rex JH, Shafer RW, White NJ, Treanor JJ eds. Antimicrobial Therapy and Vaccines, Volume I: Microbes. New York, NY: Apple Trees Productions; 2002:631-58.